Skip to main content
. 2020 Mar 10;61(3):260–268. doi: 10.4111/icu.2020.61.3.260

Table 3. External validation of the calculator for 5-year mortality.

Patients group No. Mean predictive rate 95% CI Actual rate
Overall 916 0.7192 0.4494 to 0.9684 0.8280
Neutrophil/lymphocyte ratio
 <4 643 0.7002 0.4494 to 0.8786 0.7994
 ≥4 184 0.9356 0.8326 to 0.9850 0.9293
Synchronous metastasis
 Absent 462 0.6036 0.4494 to 0.9010 0.7554
 Present 448 0.8618 0.7330 to 0.9850 0.8996
No. of metastasis
 <2 379 0.6864 0.4494 to 0.9550 0.7652
 ≥2 476 0.8005 0.5404 to 0.9850 0.8824
Albumin (g/dL)
 ≥3 728 0.7377 0.4494 to 0.9684 0.8132
 <3 51 0.9528 0.8219 to 0.9850 0.9804
Hb (g/dL)
 ≥LLN (male 13, female 11.5) 372 0.6475 0.4494 to 0.9436 0.7473
 <LLN (male 13, female 11.5) 458 0.8321 0.5989 to 0.9850 0.8930

CI, confidence interval; Hb, hemoglobin; LLN, lower limit of normal.